Drug intelligence / Profile preview

Sicpin

Development stage
Preclinical
Lead developer
National Institutes of Health
Modality
Recombinant Proteins and Enzymes
01

Overview

Sicpin is an immunomodulatory salivary protein isolated from the blackfly *Simulium nigrimanum*. It acts as a complement inhibitor, targeting complement component 3 (C3) to block all three pathways of complement activation (classical, lectin, and alternative). By binding to C3, Sicpin induces a conformational change that prevents its interaction with C3 convertase, thereby inhibiting downstream complement protein deposition and complement-mediated lysis and inflammation. Additionally, Sicpin has been shown to bind to the CD4 receptor and reduce T and B cell proliferation. In preclinical animal models of acute lung injury and sepsis, Sicpin has demonstrated anti-inflammatory activity and enhanced survival, suggesting potential therapeutic utility in complement-mediated inflammatory disorders.

02

Targets

C3CD4 (T lymphocyte surface antigen)

Beyond the preview

Go deeper on Sicpin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sicpin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call